Results 91 to 100 of about 7,580 (249)

Oxytocin and cabergoline alleviate ovarian hyperstimulation syndrome (OHSS) by suppressing vascular endothelial growth factor (VEGF) in an experimental model

, 2020
Purpose Ovarian hyperstimulation syndrome (OHSS) is a life-threatening complication of ovarian stimulation in reproductive medicine. Here, we aimed to investigate the role of oxytocin (OT) and cabergoline in the prevention and alleviation of the OHSS in ...
Erbas, Oytun, Ozceltik, Gokay, Tavmergen, Erol, Tavmergen Goker, Ege Nazan, Yigitturk, Gurkan, Hortu, Ismet, Karadadas, Elif, Gurkan Yigitturk, Yigitturk, G., Elif Karadadas, Tavmergen Goker, E.N., Erol Tavmergen, Erbas, O., Oytun Erbas, Ege Nazan Tavmergen Goker, Karadadas, E., Ismet Hortu, Gokay Ozceltik, Hortu, I., Tavmergen, E., Ozceltik, G.   +20 more
core   +1 more source

Severe OHSS: An `epidemic' of severe OHSS: a price we have to pay? [PDF]

Human Reproduction, 1999
M A, Graf, R, Fischer
openaire   +4 more sources

Outpatient management of severe early OHSS by administration of GnRH antagonist in the luteal phase: an observational cohort study [PDF]

, 2012
Background Management of established severe OHSS requires prolonged hospitalization, occasionally in intensive care units, accompanied by multiple ascites punctures, correction of intravascular fluid volume and electrolyte imbalance.
Kolibianakis Efstratios M, Kolibianakis, Efstratios, Efstratios M Kolibianakis, George K Petsas, Basil C Tarlatzis, Tarlatzis, Basil, Trifon G Lainas, Sfontouris, Ioannis IA, Lainas, Trifon TG, Ioannis Z Zorzovilis, George T Lainas, Petsas, George GK, Lainas Trifon G, Theoni B Tarlatzi, Sfontouris Ioannis A, Tarlatzis Basil C, Tarlatzi Theoni B, Lainas George T, Lainas, George GT, Zorzovilis, Ioannis IZ, Ioannis A Sfontouris, Petsas George K, Tarlatzi, Theoni, Zorzovilis Ioannis Z   +23 more
core   +1 more source

Incidence of OHSS by grade in the two trials and combined.

, 2016
Incidence of OHSS by grade in the two trials and combined.
Silvia Trevisan (3176376), Jakob Doblinger (3176373), Barbara Cometti (3176367), Georg Griesinger (3176370)   +3 more
core   +1 more source

Myo-inositol is a promising treatment for the prevention of ovarian hyperstimulation syndrome (OHSS): an animal study [PDF]

, 2015
Purpose To evaluate the efficacy of myo-inositol (MI) pretreatment in ...
Turan, Guluzar Arzu, Sivrikoz, Oya Nermin, Tatar, Sumeyra, Gur, Esra Bahar, Adakan, Saban, Sumeyra Tatar, Nur Sahin, Sahin, Nur, YILMAZ, OSMAN, Fatma Eskicioglu, Hakan Cengiz, Esra Bahar Gur, Saban Adakan, Osman Yilmaz, Guluzar Arzu Turan, Oya Nermin Sivrikoz, Cengiz, Hakan, Eskicioglu, Fatma   +17 more
core   +1 more source

Severe OHSS rate of GnRH long agonist protocol versus GnRH antagonist protocol per woman.

, 2014
Severe OHSS rate of GnRH long agonist protocol versus GnRH antagonist protocol per woman.
Lin Li (28817), Dongzi Yang (468047), Wenjun Wang (314231), Qingxue Zhang (538934), Haiyan Lin (116227), Yu Li (183836)   +5 more
core   +1 more source

The Effectiveness of Cabergoline for the Prevention of Ovarian Hyperstimulation Syndrome [PDF]

Iranian Journal of Medical Sciences, 2011
Type 2 receptors for vascular endothelial growth factor are believed to be involved in the pathophysiology of ovarian hyperstimulation syndrome (OHSS).
Marzieh Agha Hosseini, Ashraf Aleyasin, Atossa Mahdavi, Romina Nezami, Leila Safdarian   +4 more
doaj  

Meta-analysis of GnRH antagonist protocols: do they reduce the risk of OHSS in PCOS?

, 2012
This systematic review and meta-analysis investigated whether gonadotrophin-releasing hormone (GnRH) antagonist protocols reduce the risk of ovarian hyperstimulation syndrome (OHSS) in women with polycystic ovary syndrome undergoing IVF compared with the
Sesh Kamal Sunkara, Khalaf, Yakoub, Yacoub Khalaf, Jyotsna Pundir, Tarek El-Toukhy, Sunkara, Sesh Kamal, Pundir, Jyotsna, El-Toukhy, Tarek   +7 more
core   +1 more source

Clinical parameters of ovarian hyperstimulation syndrome (OHSS) following different hormonal triggers of oocyte maturation in IVF treatment'

, 2018
This paper presents independent research funded by grants from the MRC, BBSRC and NIHR and supported by the NIHR Clinical Research Facility and Biomedical Research Centre at Imperial College Healthcare NHS Trust.Objective.
G. Christopoulos, P. Humaidan, S.A. Clarke, R. Salim, Abbara, A., Vuong, T.N.L., Comninos, A. N., Salim, R., Trew, G.H., Clarke, S. A., S.A. Lavery, Jeffers, L., Dhillo, W.S., T.W. Kelsey, R. Islam, L. Jeffers, Lavery, S. A., A.N. Comninos, T.N.L. Vuong, Christopoulos, G., W.S. Dhillo, Kelsey, T. W., Islam, R., G.H. Trew, Humaidan, P., A. Abbara, Abbara, Ali, Salim, Rehan, Islam, Rumana, Jeffers, Lisa, Christopoulos, Georgios, Dhillo, Waljit, Humaidan, Peter, Lavery, Stuart, Comninos, Alexander, Kelsey, Tom, Trew, Geoffrey, Clarke, S, Vuong, Lan, Kelsey, T. W.; id_orcid   +39 more
core   +2 more sources

The effects of formoterol on the serum, peritoneal VEGF, MDA, and VEGF levels in the ovaries and endometrium of rats with OHSS

, 2017
Purpose: To investigate the effects of formoterol (a beta2-adrenoreceptor agonist) on serum and peritoneal fluid VEGF, malondialdehyde (MDA) levels, and on VEGF-stained cell counts in the ovaries and endometrium of rats with ovarian hyperstimulation ...
Oruc, A. S., Han, O., Kalem, M. N., Timur, H., Inal, H. A., Inal, Z. H. Ozturk, Yilmaz, N.   +6 more
core   +1 more source